Immunohistochemical analysis of growth mechanisms in juvenile nasopharyngeal angiofibroma

European Archives of Oto-Rhino-Laryngology

Volumn 264, Issue 4, 2007, Pages 389-394

  Schuon, Robert ^a,d   Brieger, Jürgen ^a   Heinrich, Ulf R ^a   Roth, Yeduha ^a,c   Szyfter, Witold ^a,b   Mann, Wolf J ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^c WOLFSON MEDICAL CENTER   (Israel)

^d JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Angiogenesis; bFGF; FLK; FLT; Hypoxia; Juvenile nasopharyngeal angiofibroma; TGF 1

Indexed keywords

ANGIOGENIC FACTOR; BASIC FIBROBLAST GROWTH FACTOR; GROWTH FACTOR RECEPTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MONOCLONAL ANTIBODY; TRANSFORMING GROWTH FACTOR BETA1; TUMOR MARKER; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ARTICLE; CANCER GROWTH; CARCINOGENESIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; NASOPHARYNX FIBROMA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RETROSPECTIVE STUDY; STROMA CELL; TUMOR VASCULARIZATION;

ADOLESCENT; ADULT; ANGIOFIBROMA; FEMALE; FIBROBLAST GROWTH FACTOR 2; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LYMPHOTOXIN-ALPHA; MALE; NASOPHARYNGEAL NEOPLASMS; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 33847661500     PISSN: 09374477     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00405-006-0202-z     Document Type: Article

References (28)

1. Fisch U (1983) The infratemporal fossa approach for nasopharyngeal tumors. Laryngoscope 93(1):36-44
2. Amedee R, Klaeyle D, Mann W, Geyer H (1989) Juvenile angiofibromas: a 40-year surgical experience. ORL J Otorhinolaryngol Relat Spec 51(1):56-61
3. Mann WJ, Jecker P, Amedee RG (2004) Juvenile angiofibromas: changing surgical concept over the last 20 years. Laryngoscope 114(2):291-293
4. Stiller D, Kuttner K (1988) Growth patterns of juvenile nasopharyngeal fibromas. A histological analysis on the basis of 40 cases. Zentralbl Allg Pathol 134(4-5):409-422
5. Zhang PJ, Weber R, Liang HH, Pasha TL, LiVolsi VA (2003) Growth factors and receptors in juvenile nasopharyngeal angiofibroma and nasal polyps: an immunohistochemical study. Arch Pathol Lab Med 127(11):1480-1484
6. Hagen R, Romalo G, Schwab B, Hoppe F, Schweikert HU (1994) Juvenile nasopharyngeal fibroma: androgen receptors and their significance for tumor growth. Laryngoscope 104(9):1125-1129
7. Brentani MM, Butugan O, Oshima CT, Torloni H, Paiva LJ (1989) Multiple steroid receptors in nasopharyngeal angiofibromas. Laryngoscope 99(4):398-401
8. Hwang HC, Mills SE, Patterson K, Gown AM (1998) Expression of androgen receptors in nasopharyngeal angiofibroma: an immunohistochemical study of 24 cases. Mod Pathol 11(11):1122-1126
9. Farag MM, Ghanimah SE, Ragaie A, Saleem TH (1987) Hormonal receptors in juvenile nasopharyngeal angiofibroma. Laryngoscope 97(2):208-211
10. Gatalica Z (1998) Immunohistochemical analysis of steroid hormone receptors in nasopharyngeal angiofibromas. Cancer Lett 127(1-2):89-93
11. Labra A, Chavolla-Magana R, Lopez-Ugalde A, Alanis-Calderon J, Huerta-Delgado A (2004) Flutamide as a preoperative treatment in juvenile angiofibroma (JA) with intracranial invasion: report of 7 cases. Otolaryngol Head Neck Surg 130(4):466-469
12. Gates GA, Rice DH, Koopmann CF Jr, Schuller DE (1992) Flutamide-induced regression of angiofibroma. Laryngoscope 102(6):641-644
13. Dillard DG, Cohen C, Muller S, Del Gaudio J, Reichman O, Parrish B, Rackley D, Gal AA (2000) Immunolocalization of activated transforming growth factor beta1 in juvenile nasopharyngeal angiofibroma. Arch Otolaryngol Head Neck Surg 126(6):723-725
14. Bertolino P, Deckers M, Lebrin F, ten Dijke P (2005) Transforming growth factor-beta signal transduction in angiogenesis and vascular disorders (review). Chest 128(Suppl 6):585S-590S
15. Nagai MA, Butugan O, Logullo A, Brentani MM (1996) Expression of growth factors, proto-oncogenes, and p53 in nasopharyngeal angiofibromas. Laryngoscope 106(2 Pt 1):190-195
16. Schiff M, Gonzalez AM, Ong M, Baird A (1992) Juvenile nasopharyngeal angiofibroma contain an angiogenic growth factor: basic FGF. Laryngoscope 102(8):940-945
17. Brieger J, Wierzbicka M, Sokolov M, Roth Y, Szyfter W, Mann WJ (2004) Vessel density, proliferation, and immunolocalization of vascular endothelial growth factor in juvenile nasopharyngeal angiofibromas. Arch Otolaryngol Head Neck Surg 130(6):727-731
18. Heinrich UR, Brieger J, Selivanova O, Feltens R, Eimermacher A, Schafer D, Mann WJ (2006) COX-2 expression in the guinea pig cochlea is partly altered by moderate sound exposure. Neurosci Lett 394(2):121-126
19. Lehr HA, Mankoff DA, Corwin D, Santeusanio G, Gown AM (1997) Application of photoshop based image analysis to quantification of hormone receptor expression in breast cancer. J Histochem Cytochem 45:1559-1565
20. Lehr HA, van der Loos CM, Teeling P, Gown AM (1999) Complete chromogen separation and analysis in double immunohistochemical stains using Photoshop-based image analysis. J Histochem Cytochem 47(1):119-126
21. Presta M, Dell'Era P, Mitola S, Moroni E, Ronca R, Rusnati M (2005) Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis(review). Cytokine Growth Factor Rev 16(2):159-178
22. Saylam G, Yucel OT, Sungur A, Onerci M (2006) Proliferation, angiogenesis and hormonal markers in juvenile nasopharyngeal angiofibroma. Int J Pediatr Otorhinolaryngol 70(2):227-234
23. Roberts DM, Kearney JB, Johnson JH, Rosenberg MP, Kumar R, Bautch VL (2004) The vascular endothelial growth factor (VEGF) receptor Flt-1 (VEGFR-1) modulates Flk-1 (VEGFR-2) signaling during blood vessel formation. Am J Pathol 164(5):1531-1535
24. Fukumura D, Xavier R, Sugiura T, Chen Y, Park EC, Lu N, Selig M, Nielsen G, Taksr T, Jain RK, Seed B (1998) Tumor induction of VEGF promoter activity in stromal cells. Cell 94:715-725
25. Hlatky L, Tsionou C, Hahnfeldt P, Coleman CN (1994) Mammary fibroblasts may influence breast tumour angiogenesis via hypoxia-induced vascular endothelial growth factor upregulation and protein expression. Cancer Res 54:6083-6086
26. Pilch H, Schlenger K, Steiner E, Brockerhoff P, Knapstein P, Vaupel P (2001) Hypoxia-stimulated expression of angiogenic growth factors in cervical cancer cells and cervical cancer-derived fibroblasts. Int J Gynecol Cancer 11:137-142
27. Metzen E, Ratcliffe PJ (2004) HIF hydroxylation and cellular oxygen sensing (review). Biol Chem 385(3-4):223-230
28. Rosen L, Gordon MS (2006) Overview of anti-VEGF therapy and angiogenesis. Part 1: angiogenesis inhibition in solid tumor malignancies. Clin Adv Hematol Oncol 4(1) suppl 1-10 pp 11-12